 <h1>Valstar Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>valrubicin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about valrubicin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Valstar.</p><h2>In Summary</h2><p><b>Common side effects of Valstar include:</b> cystitis, bladder pain, bladder spasm, dysuria, hematuria, urinary frequency, urinary incontinence, and urinary urgency. <b>Other side effects include:</b> nocturia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to valrubicin: intravesical solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, valrubicin (the active ingredient contained in Valstar) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of valrubicin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Blood in urine</li>
<li>loss of bladder control </li>
<li>painful or difficult urination</li>
<li> red color in urine</li>
<li>strong urge to urinate</li>
<li>unusually frequent urination</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Increased urination at night</li>
<li>local burning sensation</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Frequent urge to defecate</li>
<li>itching</li>
<li>loss of sense of taste</li>
</ul><p>
<!-- end intravesical solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to valrubicin: intravesical solution</i></p><h3>Local</h3><p>Local adverse reactions associated with valrubicin (the active ingredient contained in Valstar) usually occurred during or shortly after instillate and resolve within one to seven days after the instillation is removed from the bladder.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Any local bladder symptom (88%)</p>
<p><b>Common</b> (1% to 10%): Procedure related local burning symptoms<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary frequency (61%), urinary urgency (57%), dysuria (56%), bladder spasm (31%), hematuria (29%), bladder pain (28%), urinary incontinence (22%), urinary tract infection (15%), cystitis (15%) </p>
<p><b>Common</b> (1% to 10%): Nocturia, urinary retention, microscopic hematuria, urethral pain, pelvic pain, gross hematuria</p>
<p><b>Frequency not reported</b>: Poor urine flow, urethritis<sup>[Ref]</sup></p><h3>General</h3><p>The most common side effects were local bladder symptoms, including urinary frequency, urinary urgency, and dysuria.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, diarrhea, vomiting, flatulence </p>
<p><b>Frequency not reported</b>: Tenesmus<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness </p>
<p><b>Frequency not reported</b>: Taste loss<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p>
<p><b>Frequency not reported</b>: Pruritus, local skin irritation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Vasodilation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperglycemia, peripheral edema </p>
<p><b>Frequency not reported</b>: Nonprotein nitrogen increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, myalgia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, malaise, chest pain, fever</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Valstar (valrubicin)." Medeva Pharmaceuticals, Rochester, NY. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Valstar (valrubicin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: antibiotics/antineoplastics</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Valstar &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Urinary Tract Tumors</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to valrubicin: intravesical solution</i></p><h3>Local</h3><p>Local adverse reactions associated with valrubicin (the active ingredient contained in Valstar) usually occurred during or shortly after instillate and resolve within one to seven days after the instillation is removed from the bladder.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Any local bladder symptom (88%)</p><p><b>Common</b> (1% to 10%): Procedure related local burning symptoms<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary frequency (61%), urinary urgency (57%), dysuria (56%), bladder spasm (31%), hematuria (29%), bladder pain (28%), urinary incontinence (22%), urinary tract infection (15%), cystitis (15%) </p><p><b>Common</b> (1% to 10%): Nocturia, urinary retention, microscopic hematuria, urethral pain, pelvic pain, gross hematuria</p><p><b>Frequency not reported</b>: Poor urine flow, urethritis<sup>[Ref]</sup></p><h3>General</h3><p>The most common side effects were local bladder symptoms, including urinary frequency, urinary urgency, and dysuria.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Abdominal pain, nausea, diarrhea, vomiting, flatulence </p><p><b>Frequency not reported</b>: Tenesmus<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dizziness </p><p><b>Frequency not reported</b>: Taste loss<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash</p><p><b>Frequency not reported</b>: Pruritus, local skin irritation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Vasodilation<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Anemia<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Hyperglycemia, peripheral edema </p><p><b>Frequency not reported</b>: Nonprotein nitrogen increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, myalgia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, malaise, chest pain, fever</p><p id="ref_1">1. "Product Information. Valstar (valrubicin)." Medeva Pharmaceuticals, Rochester, NY. </p><h2>More about Valstar (valrubicin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: antibiotics/antineoplastics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Valstar &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Urinary Tract Tumors</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>